Impact of physical activity and bodyweight on health-related quality of life in people with type 2 diabetes

Código QR

Impact of physical activity and bodyweight on health-related quality of life in people with type 2 diabetes

Katharina EckertInstitute of Exercise and Public Health, Faculty of Sport Science, University of Leipzig, Leipzig, GermanyPurpose: Increasing obesity prevalence rates in the general population are reflected in patients with type 2 diabetes. Health-related quality of life (HRQoL) is negatively affect...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Eckert K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/fe8ff29972114a30ae3f206178c5e548
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Impact of obesity and type 2 diabetes on health-related quality of life in the general population in England
por: Stephen CL Gough, et al.
Publicado: (2009)

Health-related quality of life in type 1 and type 2 diabetic patients in a Portuguese central public hospital
por: Sepúlveda E, et al.
Publicado: (2015)

Relationship between chronic complications, hypertension, and health-related quality of life in Portuguese patients with type 2 diabetes
por: Sepúlveda E, et al.
Publicado: (2015)

Comparison of demographic and clinical characteristics influencing health-related quality of life in patients with diabetic foot ulcers and those without foot ulcers
por: Yekta Z, et al.
Publicado: (2011)

Health-related quality of life, adiposity, and sedentary behavior in patients with early schizophrenia: preliminary study
por: Strassnig M, et al.
Publicado: (2012)

Metabolic factors that affect health-related quality of life in type 2 diabetes patients: a multivariate regression analysis
por: Dehesh T, et al.
Publicado: (2019)

Decreased health-related quality of life in patients with diabetic foot problems
por: Sothornwit J, et al.
Publicado: (2018)

Health outcomes in diabetics measured with Minnesota Community Measurement quality metrics
por: Takahashi PY, et al.
Publicado: (2014)

Health-Related Quality of Life and Associated Factors Among Type Two Diabetic Patients on Follow-Up in Dessie Comprehensive Specialized Hospital, Dessie, North East Ethiopia, 2020
por: Girma M, et al.
Publicado: (2020)

Health-Related Quality of Life and Associated Factors Among Type Two Diabetic Patients on Follow-Up in Dessie Comprehensive Specialized Hospital, Dessie, North East Ethiopia, 2020 [Corrigendum]
por: Girma M, et al.
Publicado: (2021)

Type 2 diabetes mellitus and the cardiometabolic syndrome: impact of incretin-based therapies
por: Stanley Schwartz, et al.
Publicado: (2010)

Using the health action process approach to predict and improve health outcomes in individuals with type 2 diabetes mellitus
por: MacPhail M, et al.
Publicado: (2014)

AMPK activation: a therapeutic target for type 2 diabetes?
por: Coughlan KA, et al.
Publicado: (2014)

Saxagliptin for type 2 diabetes
por: Antonio R Chacra, et al.
Publicado: (2010)

Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
por: Mazzilli R, et al.
Publicado: (2015)

Evaluating the impact of type 2 diabetes mellitus on cardiovascular risk in persons with metabolic syndrome using the UKPDS risk engine
por: Ogedengbe OS, et al.
Publicado: (2015)

Diabetes-Related Distress Among People with Type 2 Diabetes in Ho Chi Minh City, Vietnam: Prevalence and Associated Factors
por: Huynh G, et al.
Publicado: (2021)

Depression in people with type 2 diabetes: current perspectives
por: Darwish L, et al.
Publicado: (2018)

Type 2 diabetes in Brazil: epidemiology and management
por: Almeida-Pititto B, et al.
Publicado: (2015)

Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions
por: Angel Rodr&iacute;guez, et al.
Publicado: (2010)

Sotagliflozin improves glycemic control in nonobese diabetes-prone mice with type 1 diabetes
por: Powell DR, et al.
Publicado: (2015)

Analog insulin detemir for patients with type 1 and type 2 diabetes: a review
por: Gregory E Peterson
Publicado: (2009)

Linking obesity with type 2 diabetes: the role of T-bet
por: Wali JA, et al.
Publicado: (2014)

Comparative effectiveness of liraglutide in the treatment of type 2 diabetes
por: Rigato M, et al.
Publicado: (2014)

Risk management in the treatment of type 2 diabetes with pioglitazone
por: Giuseppe Derosa, et al.
Publicado: (2009)

Importance of family/social support and impact on adherence to diabetic therapy
por: Miller TA, et al.
Publicado: (2013)

Evidence for the benefit of exercise therapy in patients with type 2 diabetes
por: Madden KM
Publicado: (2013)

Insulin detemir for the treatment of obese patients with type 2 diabetes
por: Hollander PA
Publicado: (2012)

Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
por: Shannon A Miller, et al.
Publicado: (2009)

Red cell distribution width in type 2 diabetic patients
por: Nada AM
Publicado: (2015)

Fixed combination of repaglinide and metformin in the management of type 2 diabetes
por: Robert Moses
Publicado: (2009)

Minimizing the risk of hypoglycemia in patients with type 2 diabetes mellitus
por: Pamela Kushner
Publicado: (2010)

Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes
por: Henri K Parson, et al.
Publicado: (2010)

Pharmacology, efficacy and safety of liraglutide in the management of type 2 diabetes
por: Joshua J Neumiller, et al.
Publicado: (2010)

Biphasic insulin aspart 30/70 (BIAsp 30) in the treatment of type 1 and type 2 diabetes
por: Paul Valensi
Publicado: (2009)

A psychometric evaluation of the Diabetes Symptom Checklist-Revised (DSC-R) cognitive distress, fatigue, hyperglycemia, and hypoglycemia subscales in patients with type 1 and type 2 diabetes
por: April N Naegeli, et al.
Publicado: (2010)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
por: Michael A Via, et al.
Publicado: (2010)

Akt/PKB activation and insulin signaling: a novel insulin signaling pathway in the treatment of type 2 diabetes
por: Mackenzie RWA, et al.
Publicado: (2014)

Optimal management of type 2 diabetes in patients with increased risk of hypoglycemia
por: Anderson M, et al.
Publicado: (2014)

Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence
por: Sosale A, et al.
Publicado: (2015)